Salvia BioElectronics is an innovative Dutch start-up founded in 2017 that is developing a minimally-invasive implantable neurostimulation device for the treatment of chronic migraine. The product aim is to provide patients with a drug-free solution that is effective, inherently side-effect free and widely accessible.
As of today, a vast portion of chronic migraine patients are drug refractory and therefore left without any treatment option.
Location: Netherlands, North Brabant, Eindhoven
Employees: 11-50
Total raised: $30.44M
Founded date: 2017
Investors 3
Date | Name | Website |
- | Panakes Pa... | panakes.it |
06.12.2020 | Dolby Fami... | dolbyventu... |
- | SHS Gesell... | shs-capita... |
Funding Rounds 1
Date | Series | Amount | Investors |
22.09.2020 | - | $30.44M | - |
Mentions in press and media 5
Date | Title | Description | Source |
23.09.2020 | This Eindhoven-based startup is developing a new bioelectron... | Migraine is the first cause of disability in under 50s, affecting one out of seven people, predomina... | siliconcan... |
22.09.2020 | SHS Gesellschaft für Beteiligungsmanagement mbH : Salvia Bio... | DGAP-News: SHS Gesellschaft für Beteiligungsmanagement mbH / Key word(s): Investment/Financing Salv... | marketscre... |
22.09.2020 | Salvia BioElectronics raises EUR 26M (USD 31M) to develop in... | Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for ch... | panakes.it... |
22.09.2020 | Salvia BioElectronics raises EUR 26M (USD 31M) to develop in... | - | dolbyventu... |
20.12.2019 | 8 innovative healthtech startups from Eindhoven that raised ... | Earlier, heathtech startups were those that provide enterprise, diagnostic, etc. This scenario has w... | siliconcan... |